Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study.
暂无分享，去创建一个
A. Salar | R. Bouabdallah | G. Follows | I. Avivi | O. Shpilberg | P. Sayyed | Andrew Haynes | M. Pedersen | J. Pereira | F. Hourcade‐Potelleret | M. Brewster | B. Bittner | O. Catalani | A. Janíková | C. McIntyre | G. Tumyan | J. Larouche | Olivier Catalani